EBITDA: Income before interest, taxes, depreciation and amortization.
China Pharma Holdings, Inc. (CPHI) had EBITDA of $-1.97M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$4.53M |
|
$-4.74M |
|
$6.51M |
|
$-1.99M |
|
$9.12M |
|
$-4.59M |
|
$-0.15M |
|
$-4.74M |
|
$-4.74M |
|
$-4.74M |
|
$-4.74M |
|
$-4.74M |
|
$-4.74M |
|
$-4.59M |
|
|
EBITDA |
$-1.97M |
1.75M |
|
1.75M |
|
$-2.70 |
|
$-2.70 |
|
| Balance Sheet Financials | |
$3.27M |
|
$4.88M |
|
$11.62M |
|
$14.89M |
|
$5.02M |
|
$1.39M |
|
$2.12M |
|
$7.14M |
|
$7.75M |
|
$1.05M |
|
$7.75M |
|
3.26M |
|
| Cash Flow Statement Financials | |
$-0.47M |
|
$-0.29M |
|
$0.03M |
|
$1.42M |
|
$0.63M |
|
$-0.80M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.65 |
|
-- |
|
-- |
|
0.15 |
|
0.31 |
|
-43.84% |
|
-101.32% |
|
-101.32% |
|
-43.52% |
|
-104.58% |
|
-104.58% |
|
$-0.50M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
2.87 |
|
17.26 |
|
21.15 |
|
-61.13% |
|
-450.02% |
|
-31.81% |
|
-51.83% |
|
$2.38 |
|
$-0.29 |
|
$-0.27 |
|